Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):8978-8987. doi: 10.26355/eurrev_202009_22840.
Extracellular vesicles (EVs) are small lipid-encapsulated vesicles secreted from specific cells that can be taken up by other cells, thereby allowing for the efficient transport of macromolecules such as lipids, proteins, and nucleic acids between tissues and organs in vivo. These EVs have been found to play critical roles in normal tissue homeostasis and disease development, serving to regulate complex processes, including inflammation, immunity, and angiogenesis. At present, the leading global cause of the end-stage renal disease (ESRD) is diabetic kidney disease (DKD), with the prevalence of this latter condition being predicted to increase in the near future due to rising type 2 diabetes mellitus (T2DM) incidence. Recent work from several research groups has highlighted a potential role for EVs in the development of DKD. The present review, therefore, serves to explore the relevance of EVs to the development, detection, and treatment of DKD in an effort to better understand this complex disease state.
细胞外囊泡(EVs)是由特定细胞分泌的小脂质包裹囊泡,可以被其他细胞摄取,从而允许在体内组织和器官之间有效运输脂类、蛋白质和核酸等大分子。这些 EVs 在正常组织稳态和疾病发展中发挥着关键作用,可调节包括炎症、免疫和血管生成在内的复杂过程。目前,终末期肾病(ESRD)的全球主要病因是糖尿病肾病(DKD),由于 2 型糖尿病(T2DM)发病率上升,预计未来这种疾病的患病率将会增加。最近,几个研究小组的工作强调了 EVs 在 DKD 发展中的潜在作用。因此,本综述旨在探讨 EVs 在 DKD 的发展、检测和治疗中的相关性,以更好地了解这种复杂的疾病状态。